Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Tmi Acquisition LLC operates in the Biotechnology & Pharmaceuticals technology area. The portfolio currently contains 1 pending office action. This action is assigned to 1 distinct examiner and 1 distinct art unit. This configuration indicates that the company's current patent applications are being processed through a centralized administrative channel.
WHEELER, THURMAN MICHAEL is the busiest examiner for the portfolio, with 1 pending office action. For the practitioner, this means that the 1 pending office action is subject to the specific examination style and history of WHEELER, THURMAN MICHAEL. Because the portfolio involves 1 distinct examiner, the company can focus its resources on the preferences of this individual rather than managing diverse perspectives.
The involvement of 1 distinct art unit suggests that the subject matter of the pending office action is confined to a specific technical niche within the Biotechnology & Pharmaceuticals technology area. This concentration simplifies the management of the portfolio, as the prosecution is not divided across art units. The current data reflects a targeted approach to patent acquisition, with all active prosecution consolidated under these specific designations.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WHEELER, THURMAN MICHAEL | 1 | 45.8% | +23.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16785549 | SEMI-PERMANENT TATTOOS | WHEELER, THURMAN MICHAEL | 29d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 16785549 | SEMI-PERMANENT TATTOOS | WHEELER, THURMAN MICHAEL | 29d |
| Art Unit | Apps |
|---|---|
| 1619 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 16785549 | SEMI-PERMANENT TATTOOS | WHEELER, THURMAN MICHAEL | 1619 | §103§112 | Final Rejection | 29d | Pending | Feb 07, 2020 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTmi Acquisition LLC has 1 pending office actions as of November 2026, spread across 1 art units and 1 examiners.
Thurman Michael Wheeler has the most, with 1 of Tmi Acquisition LLC's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.